PATENT CLAIM ANALYSIS

Application Number: 16195811
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 15):
An enucleated erythroid cell comprising at least 1,000 copies of an intracellular exogenous polypeptide comprising phenylalanine ammonia lyase (PAL),\n wherein the exogenous polypeptide is not fused to an endogenous polypeptide, and wherein the enucleated erythroid cell is made by a process comprising introducing into a nucleated erythroid cell precursor an exogenous nucleic acid encoding the exogenous polypeptide.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15824877', '15783921', '15925212', '15473421', '14738414']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7049515839985316
- 35 USC 102 Novelty (BERT): 0.5982146947050963
- Combined Prediction Score: 0.6942778950691881
- Mean Citation Score: 588.83021
- Max Citation Score: 603.0907
- Similarity Product: 531.5202451277911

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test